VANDA PHARMACEUTICALS INC. Other Income
VANDA PHARMACEUTICALS INC. (VNDA) reported Other Income of $1.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. other income for the quarter ending 2026-06-30 was $1.43M, a 60.59% decline year-over-year.
- VANDA PHARMACEUTICALS INC. other income for the quarter ending 2026-03-31 was $1.80M, a 50.82% decline year-over-year.
- VANDA PHARMACEUTICALS INC. other income for the quarter ending 2025-12-31 was $2.35M, a 37.84% decline year-over-year.
- VANDA PHARMACEUTICALS INC. other income for the quarter ending 2025-09-30 was $2.89M, a 39.15% decline year-over-year.
- VANDA PHARMACEUTICALS INC. other income for fiscal 2025 was $12.52M, a 29.42% decline from fiscal 2024.
- VANDA PHARMACEUTICALS INC. other income for fiscal 2024 was $17.74M, a 12.58% decline from fiscal 2023.
- VANDA PHARMACEUTICALS INC. other income for fiscal 2023 was $20.29M, a 308.19% increase from fiscal 2022.
- VANDA PHARMACEUTICALS INC. other income for fiscal 2022 was $4.97M, a 2397.99% increase from fiscal 2021.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.43M 10-Q · filed 2026-08-06 | $3.23M 10-Q · filed 2026-08-06 | $5.58M derived: sum of 3 quarters · filed 2026-08-06 | $8.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.80M 10-Q · filed 2026-05-07 | $4.15M derived: sum of 2 quarters · filed 2026-05-07 | $7.04M derived: sum of 3 quarters · filed 2026-05-07 | $10.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $5.25M derived: sum of 2 quarters · filed 2026-02-12 | $8.86M derived: sum of 3 quarters · filed 2026-08-06 | $12.52M 10-K · filed 2026-02-12 |
| 2025-09-30 | $2.89M 10-Q · filed 2025-10-30 | $6.51M derived: sum of 2 quarters · filed 2026-08-06 | $10.17M 10-Q · filed 2025-10-30 | $13.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.62M 10-Q · filed 2026-08-06 | $7.28M 10-Q · filed 2026-08-06 | $11.06M derived: sum of 3 quarters · filed 2026-08-06 | $15.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.66M 10-Q · filed 2026-05-07 | $7.44M derived: sum of 2 quarters · filed 2026-05-07 | $12.20M derived: sum of 3 quarters · filed 2026-05-07 | $16.83M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $8.54M derived: sum of 2 quarters · filed 2026-02-12 | $13.17M derived: sum of 3 quarters · filed 2026-02-12 | $17.74M 10-K · filed 2026-02-12 |
| 2024-09-30 | $4.76M 10-Q · filed 2025-10-30 | $9.39M derived: sum of 2 quarters · filed 2025-10-30 | $13.96M 10-Q · filed 2025-10-30 | $19.39M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $4.63M 10-Q · filed 2025-07-31 | $9.20M 10-Q · filed 2025-07-31 | $14.63M derived: sum of 3 quarters · filed 2026-02-12 | $20.51M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $4.57M 10-Q · filed 2025-05-08 | $10.00M derived: sum of 2 quarters · filed 2026-02-12 | $15.88M derived: sum of 3 quarters · filed 2026-02-12 | $21.34M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $11.31M derived: sum of 2 quarters · filed 2026-02-12 | $16.77M derived: sum of 3 quarters · filed 2026-02-12 | $20.29M 10-K · filed 2026-02-12 |
| 2023-09-30 | $5.88M 10-Q · filed 2024-11-07 | $11.33M derived: sum of 2 quarters · filed 2024-11-07 | $14.86M 10-Q · filed 2024-11-07 | $17.84M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $5.46M 10-Q · filed 2024-08-01 | $8.98M 10-Q · filed 2024-08-01 | $11.97M derived: sum of 3 quarters · filed 2025-02-14 | $13.52M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $3.52M 10-Q · filed 2024-05-09 | $6.51M derived: sum of 2 quarters · filed 2025-02-14 | $8.06M derived: sum of 3 quarters · filed 2025-02-14 | $8.39M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $4.54M derived: sum of 2 quarters · filed 2025-02-14 | $4.87M derived: sum of 3 quarters · filed 2025-02-14 | $4.97M 10-K · filed 2025-02-14 |
| 2022-09-30 | $1.55M 10-Q · filed 2023-11-09 | $1.88M derived: sum of 2 quarters · filed 2023-11-09 | $1.99M 10-Q · filed 2023-11-09 | $1.96M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $329.00K 10-Q · filed 2023-07-28 | $434.00K 10-Q · filed 2023-07-28 | $408.00K derived: sum of 3 quarters · filed 2024-02-08 | $311.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $105.00K 10-Q · filed 2023-05-03 | $79.00K derived: sum of 2 quarters · filed 2024-02-08 | -$18.00K derived: sum of 3 quarters · filed 2024-02-08 | $217.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | -$123.00K derived: sum of 2 quarters · filed 2024-02-08 | $112.00K derived: sum of 3 quarters · filed 2024-02-08 | $199.00K 10-K · filed 2024-02-08 |
| 2021-09-30 | -$97.00K 10-Q · filed 2022-11-03 | $138.00K derived: sum of 2 quarters · filed 2022-11-03 | $225.00K 10-Q · filed 2022-11-03 | $698.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $235.00K 10-Q · filed 2022-08-04 | $322.00K 10-Q · filed 2022-08-04 | $795.00K derived: sum of 3 quarters · filed 2023-02-09 | $1.45M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $87.00K 10-Q · filed 2022-05-06 | $560.00K derived: sum of 2 quarters · filed 2023-02-09 | $1.22M derived: sum of 3 quarters · filed 2023-02-09 | $3.14M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $1.13M derived: sum of 2 quarters · filed 2023-02-09 | $3.05M derived: sum of 3 quarters · filed 2023-02-09 | $4.42M 10-K · filed 2023-02-09 |
| 2020-09-30 | $659.00K 10-Q · filed 2021-11-04 | $2.58M derived: sum of 2 quarters · filed 2021-11-04 | $3.94M 10-Q · filed 2021-11-04 | $5.51M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.92M 10-Q · filed 2021-07-29 | $3.28M 10-Q · filed 2021-07-29 | $4.85M derived: sum of 3 quarters · filed 2022-02-24 | $6.37M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-06 | $2.93M derived: sum of 2 quarters · filed 2022-02-24 | $4.45M derived: sum of 3 quarters · filed 2022-02-24 | $6.10M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.08M derived: sum of 2 quarters · filed 2022-02-24 | $4.73M derived: sum of 3 quarters · filed 2022-02-24 | $6.22M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.52M 10-Q · filed 2020-10-29 | $3.17M derived: sum of 2 quarters · filed 2020-10-29 | $4.65M 10-Q · filed 2020-10-29 | $5.82M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $1.65M 10-Q · filed 2020-08-06 | $3.13M 10-Q · filed 2020-08-06 | $4.30M derived: sum of 3 quarters · filed 2021-02-11 | $5.33M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $1.49M 10-Q · filed 2020-05-07 | $2.65M derived: sum of 2 quarters · filed 2021-02-11 | $3.68M derived: sum of 3 quarters · filed 2021-02-11 | $4.47M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $2.20M derived: sum of 2 quarters · filed 2021-02-11 | $2.99M derived: sum of 3 quarters · filed 2021-02-11 | $3.61M 10-K · filed 2021-02-11 |
| 2018-09-30 | $1.03M 10-Q · filed 2019-11-07 | $1.82M derived: sum of 2 quarters · filed 2019-11-07 | $2.44M 10-Q · filed 2019-11-07 | $2.84M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $788.00K 10-Q · filed 2019-08-01 | $1.41M 10-Q · filed 2019-08-01 | $1.81M derived: sum of 3 quarters · filed 2020-02-26 | $2.21M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $622.00K 10-Q · filed 2019-05-03 | $1.02M derived: sum of 2 quarters · filed 2020-02-26 | $1.42M derived: sum of 3 quarters · filed 2020-02-26 | $1.81M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $795.00K derived: sum of 2 quarters · filed 2020-02-26 | $1.19M derived: sum of 3 quarters · filed 2020-02-26 | $1.47M 10-K · filed 2020-02-26 |
| 2017-09-30 | $396.00K 10-Q · filed 2018-11-07 | $793.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.07M 10-Q · filed 2018-11-07 | $1.23M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $397.00K 10-Q · filed 2018-08-02 | $677.00K 10-Q · filed 2018-08-02 | $831.00K derived: sum of 3 quarters · filed 2019-02-19 | $1.05M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $280.00K 10-Q · filed 2018-05-02 | $434.00K derived: sum of 2 quarters · filed 2019-02-19 | $657.00K derived: sum of 3 quarters · filed 2019-02-19 | $828.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $377.00K derived: sum of 2 quarters · filed 2019-02-19 | $548.00K derived: sum of 3 quarters · filed 2019-02-19 | $665.00K 10-K · filed 2019-02-19 |
| 2016-09-30 | $223.00K 10-Q · filed 2017-11-08 | $394.00K derived: sum of 2 quarters · filed 2017-11-08 | $511.00K 10-Q · filed 2017-11-08 | $606.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $171.00K 10-Q · filed 2017-08-03 | $288.00K 10-Q · filed 2017-08-03 | $383.00K derived: sum of 3 quarters · filed 2018-02-15 | $463.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $117.00K 10-Q · filed 2017-05-03 | $212.00K derived: sum of 2 quarters · filed 2018-02-15 | $292.00K derived: sum of 3 quarters · filed 2018-02-15 | $364.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $175.00K derived: sum of 2 quarters · filed 2018-02-15 | $247.00K derived: sum of 3 quarters · filed 2018-02-15 | $320.00K 10-K · filed 2018-02-15 |
| 2015-09-30 | $80.00K 10-Q · filed 2016-11-03 | $152.00K derived: sum of 2 quarters · filed 2016-11-03 | $225.00K 10-Q · filed 2016-11-03 | $250.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $72.00K 10-Q · filed 2016-07-28 | $144.00K 10-Q · filed 2016-07-28 | $170.00K derived: sum of 3 quarters · filed 2017-02-17 | $192.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $72.00K 10-Q · filed 2016-05-05 | $98.00K derived: sum of 2 quarters · filed 2017-02-17 | $120.00K derived: sum of 3 quarters · filed 2017-02-17 | $151.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $48.00K derived: sum of 2 quarters · filed 2017-02-17 | $79.00K derived: sum of 3 quarters · filed 2017-02-17 | $124.00K 10-K · filed 2017-02-17 |
| 2014-09-30 | $22.00K 10-Q · filed 2015-11-04 | $53.00K derived: sum of 2 quarters · filed 2015-11-04 | $98.00K 10-Q · filed 2015-11-04 | $142.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $31.00K 10-Q · filed 2015-07-31 | $76.00K 10-Q · filed 2015-07-31 | $120.00K derived: sum of 3 quarters · filed 2016-02-12 | $145.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $45.00K 10-Q · filed 2015-05-07 | $89.00K derived: sum of 2 quarters · filed 2016-02-12 | $114.00K derived: sum of 3 quarters · filed 2016-02-12 | $144.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $69.00K derived: sum of 2 quarters · filed 2016-02-12 | $99.00K derived: sum of 3 quarters · filed 2016-02-12 | $145.00K 10-K · filed 2016-02-12 |
| 2013-09-30 | $25.00K 10-Q · filed 2014-10-27 | $55.00K derived: sum of 2 quarters · filed 2014-10-27 | $101.00K 10-Q · filed 2014-10-27 | $160.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $30.00K 10-Q · filed 2014-08-08 | $76.00K 10-Q · filed 2014-08-08 | $135.00K derived: sum of 3 quarters · filed 2015-03-13 | $204.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $46.00K 10-Q · filed 2014-05-08 | $105.00K derived: sum of 2 quarters · filed 2015-03-13 | $174.00K derived: sum of 3 quarters · filed 2015-03-13 | $252.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $128.00K derived: sum of 2 quarters · filed 2015-03-13 | $206.00K derived: sum of 3 quarters · filed 2015-03-13 | $561.00K 10-K · filed 2015-03-13 |
| 2012-09-30 | $69.00K 10-Q · filed 2013-11-08 | $147.00K derived: sum of 2 quarters · filed 2013-11-08 | $502.00K 10-Q · filed 2013-11-08 | $601.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $78.00K 10-Q · filed 2013-07-31 | $433.00K 10-Q · filed 2013-07-31 | $532.00K derived: sum of 3 quarters · filed 2014-02-25 | $638.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $355.00K 10-Q · filed 2013-05-10 | $454.00K derived: sum of 2 quarters · filed 2014-02-25 | $560.00K derived: sum of 3 quarters · filed 2014-02-25 | $681.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $205.00K derived: sum of 2 quarters · filed 2014-02-25 | $326.00K derived: sum of 3 quarters · filed 2014-02-25 | $461.00K 10-K · filed 2014-02-25 |
| 2011-09-30 | $106.00K 10-Q · filed 2012-11-08 | $227.00K derived: sum of 2 quarters · filed 2012-11-08 | $362.00K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $121.00K 10-Q · filed 2012-08-03 | $256.00K 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | $135.00K 10-Q · filed 2012-05-09 | |||
| 2010-12-31 | $431.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |